°Ç±¹´ëº´¿ø Çã¹Ì³ª ±³¼ö, '29ȸ °úÇбâ¼ú¿ì¼ö³í¹®»ó' ¼ö»ó

Çѱ¹°úÇбâ¼ú´ÜüÃÑ¿¬ÇÕȸ Á¦Á¤, '2019 ´ëÇѹα¹°úÇбâ¼ú¿¬Â÷´ëȸ'¼­ ½Ã»ó
´º½ºÀÏÀÚ: 2019³â07¿ù09ÀÏ 11½Ã36ºÐ

[º¸°ÇŸÀÓÁî] °Ç±¹´ëº´¿ø Áø´Ü°Ë»çÀÇÇаú Çã¹Ì³ª ±³¼ö(»çÁø)°¡ Çѱ¹°úÇбâ¼ú´ÜüÃÑ¿¬ÇÕȸ°¡ Á¦Á¤ÇÑ 'Á¦29ȸ °úÇбâ¼ú¿ì¼ö³í¹®»ó(³í¹®)'À» ¹Þ¾Ò´Ù.

½Ã»ó½ÄÀº Áö³­ 4ÀÏ ÄÚ¿¢½º¿¡¼­ ¿­¸° '2019 ´ëÇѹα¹°úÇбâ¼ú¿¬Â÷´ëȸ'¿¡¼­ Ä¡·¯Á³´Ù.

Çѱ¹°úÇбâ¼ú´ÜüÃÑ¿¬ÇÕȸ´Â Áö³­ÇØ ±¹³» ¹ßÇà ÇмúÁö¿¡ ¹ßÇ¥µÈ ³í¹® Áß °¢ ÇÐȸ¿¡¼­ ÃßõÇÑ ³í¹®À» ´ë»óÀ¸·Î ½É»çÇØ ÀÌ °¡¿îµ¥ °úÇбâ¼ú ¿ì¼ö ³í¹® ¼ö»óÀÛÀ» ¼±Á¤ÇÏ°í ÀÖ´Ù.

¼ö»ó ³í¹®Àº '¸¸¼º °£ Áúȯ¿¡¼­ °£ ¼¶À¯È­ Æò°¡¸¦ À§ÇÑ Enhanced Liver Fibrosis, Glycosylation Isomer of Mac-2 Binding Protein, Galectin-3, ±×¸®°í Soluble Suppression of Tumorigenicity 2 À¯¿ë¼º(Usefulness of Enhanced Liver Fibrosis, Glycosylation Isomer of Mac-2 Binding Protein, Galectin-3, and Soluble Suppression of Tumorigenicity 2 for Assessing Liver Fibrosis in Chronic Liver Diseases)'À¸·Î Çã ±³¼ö¿Í °Ç±¹´ëº´¿ø Áø´Ü°Ë»çÀÇÇаú ¹®Èñ¿ø ±³¼ö, ¼ÒÈ­±â³»°ú ÃÖ¿øÇõ ±³¼ö°¡ ÇÔ²² Âü¿©Çß´Ù.

ÀÌ ³í¹®Àº ¸¸¼º°£Áúȯ ȯÀÚ¿¡¼­ °£ ¼¶À¯È­ÁõÀÇ Á¤µµ¸¦ ºñħ½ÀÀûÀÎ ¹æ¹ýÀ¸·Î Æò°¡Çϱâ À§ÇØ 4Á¾·ùÀÇ »õ »ýüǥÁöÀÚµéÀ» ºñ±³ Æò°¡ÇÑ Ã¹ ³í¹®À¸·Î ÁÁÀº Æò°¡¸¦ ¹Þ¾Ò´Ù.

Çã ±³¼ö´Â "ÈǸ¢ÇÑ ¿¬±¸ÁøÀ» ´ëÇ¥ÇØ ¹ÞÀº »ó"À̶ó¸ç "¾ÕÀ¸·Î ¹ÙÀÌ¿À¸¶Ä¿ÀÇ È°¿ë ¿¬±¸¿¡ ´õ¿í ¸ÅÁøÇÒ °Í"À̶ó°í ¹àÇû´Ù.

Çã ±³¼ö´Â ÃÖ±Ù '2019 ´ëÇÑÁø´ÜÇ÷¾×ÇÐȸ¼­ ¿ì¼ö ³í¹®»ó'À» ¼ö»óÇÑ ¹Ù ÀÖÀ¸¸ç Áö³­ 2017³â¿£ Áٱ⼼Æ÷ ºÐ¾ßÀÇ ¼¼°èÀûÀÎ ÇмúÁöÀÎ 'Current Stem Cell Research and Therapy (SCI-E Àú³Î, 2016 IF 2.684)'ÀÇ ÆíÁýÀÎÀ¸·Î ÃÊû, ƯÁýÈ£¸¦ ¹ß°£Çϱ⵵ Çß´Ù.


ÀÌ ´º½ºÅ¬¸®ÇÎÀº BKT´º½º{www.bktimes.net}¿¡¼­ ¹ßÃéµÈ ³»¿ëÀÔ´Ï´Ù.